5[5]Jin L,Jin H,Zhang G,et al.Changes in coagulation and issue plasminogen activator after the treatment of cerebral infarction with lumbrokinase[J].Clin Hemorheol Microcirc,2000,23:213-218.
4[1]Markwardt F. The development of hirudin as an antithrombotic drug. Thrombosis Research, 1994,74( 1 ): 1 ～ 23.
5[2]Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Heamost, 1991 ;66(1 ): 141 ～ 152.
6[3]Vindigni V, Filippis VD, Zanotti G, et al. Probing the structure of hirudin from hirudinaria manillensis by limited proteolysis: isolation, characterization and thrombin-inhibitory properties of N-terminal fragments. Eur J Biochem,1994,226: 323 ～ 333.
7[5]Nowak G, Markwardt F. Hirudin in disseminated intravascular coagulation.Haemostasis, 1991,21 (Supple 1 ): 142 ～ 148.
8[6]Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res, 1989,54(5) :377 ～ 388.
9[7]Zawilska K, Zozulinska M, Turowiecka Z, et al. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIG) in rabbits. Thromb Res, 1993,69(3): 315 ～ 320.
10[8]Doutremepuich C, Deharo E, Guyot M, et al. Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin. Thromb Res,1989,54(5) :435 ～ 445.
